Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis

Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis

(2012) Senem Buyukkara Yilmaz et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Ustekinumab Treatment of TNF Antagonist-Induced Paradoxical Psoriasis Flare in a Patient with Psoriatic Arthritis: Case Report and Review

(2012) Lluís Puig et al.   DERMATOLOGY

Exacerbation of Infliximab-Induced Palmoplantar Psoriasis Under Ustekinumab Therapy in a Patient With Ankylosing Spondylitis

(2012) Gilles Safa et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

(2012) Shiu-Chung Au et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Treatment of Refractory Tumor Necrosis Factor Inhibitor –Induced Palmoplantar Pustulosis: A Report of 2 Cases

(2011) Derek H. Chu   ARCHIVES OF DERMATOLOGY

Management of palmoplantar pustulosis: do we need to change?

(2011) U. Mrowietz et al.   BRITISH JOURNAL OF DERMATOLOGY

Recalcitrant Palmoplantar Pustular Psoriasis Treated with Etanercept

(2011) UXUA FLORISTAN et al.   PEDIATRIC DERMATOLOGY

Ustekinumab in the treatment of palmoplantar pustulosis

(2010) S. Gerdes et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy of Ustekinumab in Palmoplantar Psoriasis

(2010) C. Bulai Livideanu et al.   DERMATOLOGY

Therapeutic options for palmoplantar pustulosis

(2009) E. Adişen et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

(2009) Antonella Di Cesare et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Functional Characterization of IL-17F as a Selective Neutrophil Attractant in Psoriasis

(2008) Hideaki Watanabe et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Palmoplantar psoriasis: a paradoxical adverse reaction induced by adalimumab

(2008) MT Bordel-Gómez et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY